Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-22-037394

Director acquired 61,111 shares (option exercise)

  • Director gave up 51,562 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gray Cameron Director 2022-06-14 Option exercise +61,111 $2.70 $165,000 738,611 D: show line 1 in the form
Gray Cameron Director 2022-06-14 Shares withheld for taxes −51,562 $3.20 $164,998 687,049 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gray Cameron Director 2022-06-14 Option exercise · Warrants −61,111 0 D: show line 3 in the form
Loading xslF345X03/doc4.xml…